323 related articles for article (PubMed ID: 31991051)
21. Inhibition of chemokine (C-X-C motif) receptor four (CXCR4) at the fetal-maternal interface during early gestation in sheep: alterations in expression of chemokines, angiogenic factors and their receptors.
Quinn KE; Prosser SZ; Kane KK; Ashley RL
J Anim Sci; 2017 Mar; 95(3):1144-11153. PubMed ID: 28380526
[TBL] [Abstract][Full Text] [Related]
22. G protein‑mediated EGFR transactivation is a common mechanism through which the CXCL12 receptors, CXCR4 and CXCR7, control human cancer cell migration.
Zieger-Naumann K; Kuhl F; Engele J
Oncol Rep; 2024 Feb; 51(2):. PubMed ID: 38099418
[TBL] [Abstract][Full Text] [Related]
23. CXCR4/CXCL12/CXCR7 axis is functional in neuroendocrine tumors and signals on mTOR.
Circelli L; Sciammarella C; Guadagno E; Tafuto S; del Basso de Caro M; Botti G; Pezzullo L; Aria M; Ramundo V; Tatangelo F; Losito NS; Ieranò C; D'Alterio C; Izzo F; Ciliberto G; Colao A; Faggiano A; Scala S
Oncotarget; 2016 Apr; 7(14):18865-75. PubMed ID: 26934559
[TBL] [Abstract][Full Text] [Related]
24. Prognostic significance of CXCL12, CXCR4, and CXCR7 in patients with breast cancer.
Wu W; Qian L; Chen X; Ding B
Int J Clin Exp Pathol; 2015; 8(10):13217-24. PubMed ID: 26722521
[TBL] [Abstract][Full Text] [Related]
25. CXCR7 prevents excessive CXCL12-mediated downregulation of CXCR4 in migrating cortical interneurons.
Abe P; Mueller W; Schütz D; MacKay F; Thelen M; Zhang P; Stumm R
Development; 2014 May; 141(9):1857-63. PubMed ID: 24718993
[TBL] [Abstract][Full Text] [Related]
26. CXCL12/CXCR4/CXCR7 axis in placenta tissues of patients with placenta previa.
Wu X; Wang Y; Li M
Open Life Sci; 2023; 18(1):20220642. PubMed ID: 37589008
[TBL] [Abstract][Full Text] [Related]
27. Scavenging of CXCL12 by CXCR7 promotes tumor growth and metastasis of CXCR4-positive breast cancer cells.
Luker KE; Lewin SA; Mihalko LA; Schmidt BT; Winkler JS; Coggins NL; Thomas DG; Luker GD
Oncogene; 2012 Nov; 31(45):4750-8. PubMed ID: 22266857
[TBL] [Abstract][Full Text] [Related]
28. Tissue factor pathway inhibitor upregulates CXCR7 expression and enhances CXCL12-mediated migration in chronic lymphocytic leukemia.
Cui XY; Tjønnfjord GE; Kanse SM; Dahm AEA; Iversen N; Myklebust CF; Sun L; Jiang ZX; Ueland T; Campbell JJ; Ho M; Sandset PM
Sci Rep; 2021 Mar; 11(1):5127. PubMed ID: 33664415
[TBL] [Abstract][Full Text] [Related]
29. The CXCR4/CXCR7/CXCL12 Axis Is Involved in a Secondary but Complex Control of Neuroblastoma Metastatic Cell Homing.
Mühlethaler-Mottet A; Liberman J; Ascenção K; Flahaut M; Balmas Bourloud K; Yan P; Jauquier N; Gross N; Joseph JM
PLoS One; 2015; 10(5):e0125616. PubMed ID: 25955316
[TBL] [Abstract][Full Text] [Related]
30. AMD3100 reduces CXCR4-mediated survival and metastasis of osteosarcoma by inhibiting JNK and Akt, but not p38 or Erk1/2, pathways in in vitro and mouse experiments.
Liao YX; Fu ZZ; Zhou CH; Shan LC; Wang ZY; Yin F; Zheng LP; Hua YQ; Cai ZD
Oncol Rep; 2015 Jul; 34(1):33-42. PubMed ID: 25997540
[TBL] [Abstract][Full Text] [Related]
31. YKL-40 promotes proliferation and invasion of HTR-8/SVneo cells by activating akt/MMP9 signalling in placenta accreta spectrum disorders.
Liu W; Wang R; Liu S; Yin X; Huo Y; Zhang R; Li J
J Obstet Gynaecol; 2023 Dec; 43(1):2211681. PubMed ID: 37192383
[TBL] [Abstract][Full Text] [Related]
32. Exploring the CXCR4/CXCR7/CXCL12 Axis in Primary Desmoid Tumors.
Baccalini EA; Renne SL; Colombo P; Pasqualini F; Quagliuolo VL; Cananzi FCM; Grizzi F; Borroni EM
Anticancer Agents Med Chem; 2023; 23(20):2248-2253. PubMed ID: 36748819
[TBL] [Abstract][Full Text] [Related]
33. CXCR4, but not CXCR7, discriminates metastatic behavior in non-small cell lung cancer cells.
Choi YH; Burdick MD; Strieter BA; Mehrad B; Strieter RM
Mol Cancer Res; 2014 Jan; 12(1):38-47. PubMed ID: 24025971
[TBL] [Abstract][Full Text] [Related]
34. CXCR7 expression correlates with tumor depth in cutaneous squamous cell carcinoma skin lesions and promotes tumor cell survival through ERK activation.
Hu SC; Yu HS; Yen FL; Chen GS; Lan CC
Exp Dermatol; 2014 Dec; 23(12):902-8. PubMed ID: 25256412
[TBL] [Abstract][Full Text] [Related]
35. Insights into the mechanism of CXCL12-mediated signaling in trophoblast functions and placental angiogenesis.
Wang L; Li X; Zhao Y; Fang C; Lian Y; Gou W; Han T; Zhu X
Acta Biochim Biophys Sin (Shanghai); 2015 Sep; 47(9):663-72. PubMed ID: 26188201
[TBL] [Abstract][Full Text] [Related]
36. Modulation of CXC-motif chemokine receptor 7, but not 4, expression is related to migration of the human prostate cancer cell LNCaP: regulation by androgen and inflammatory stimuli.
Yu L; Pham Q; Yu LL; Wang TTY
Inflamm Res; 2020 Feb; 69(2):167-178. PubMed ID: 31865399
[TBL] [Abstract][Full Text] [Related]
37. CXCL12-binding receptors expression in non-small cell lung cancer relates to tumoral microvascular density and CXCR4 positive circulating tumoral cells in lung draining venous blood.
Franco R; Pirozzi G; Scala S; Cantile M; Scognamiglio G; Camerlingo R; Botti G; Rocco G
Eur J Cardiothorac Surg; 2012 Feb; 41(2):368-75. PubMed ID: 21683606
[TBL] [Abstract][Full Text] [Related]
38. CXC chemokine receptor 7 (CXCR7) regulates CXCR4 protein expression and capillary tuft development in mouse kidney.
Haege S; Einer C; Thiele S; Mueller W; Nietzsche S; Lupp A; Mackay F; Schulz S; Stumm R
PLoS One; 2012; 7(8):e42814. PubMed ID: 22880115
[TBL] [Abstract][Full Text] [Related]
39. CXCL12 enhances human neural progenitor cell survival through a CXCR7- and CXCR4-mediated endocytotic signaling pathway.
Zhu B; Xu D; Deng X; Chen Q; Huang Y; Peng H; Li Y; Jia B; Thoreson WB; Ding W; Ding J; Zhao L; Wang Y; Wavrin KL; Duan S; Zheng J
Stem Cells; 2012 Nov; 30(11):2571-83. PubMed ID: 22987307
[TBL] [Abstract][Full Text] [Related]
40. Drug Design Targeting the CXCR4/CXCR7/CXCL12 Pathway.
Xu D; Li R; Wu J; Jiang L; Zhong HA
Curr Top Med Chem; 2016; 16(13):1441-51. PubMed ID: 26369824
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]